We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$239M
AUM Growth
+$8.32M
Cap. Flow
-$5.16M
Cap. Flow %
-2.16%
Top 10 Hldgs %
35.11%
Holding
546
New
36
Increased
93
Reduced
108
Closed
33

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$3.15M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.48M
3
DLTR icon
Dollar Tree
DLTR
+$1.94M
4
VTV icon
Vanguard Morningstar Value ETF
VTV
+$857K
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$833K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.4M
2
EOG icon
EOG Resources
EOG
+$2.91M
3
UTHR icon
United Therapeutics
UTHR
+$2.5M
4
ZBRA icon
Zebra Technologies
ZBRA
+$1.98M
5
PVH icon
PVH
PVH
+$1.43M

Sector Composition

Rank Sector Weight
1 Financials 10.55%
2 Consumer Staples 7.28%
3 Technology 6.91%
4 Consumer Discretionary 6.75%
5 Industrials 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAYX icon
501
Paychex
PAYX
$41.6B
$0 ﹤0.01%
1
– –
PTY icon
502
PIMCO Corporate & Income Opportunity Fund
PTY
$2.48B
– –
-3,300
Closed -$60K
REZI icon
503
Resideo Technologies
REZI
$5.19B
– –
-16
Closed –
SBS icon
504
Sabesp
SBS
$19.1B
$0 ﹤0.01%
41
– –
SEED icon
505
Origin Agritech
SEED
$12.1M
– –
-100
Closed -$1K
TKC icon
506
Turkcell
TKC
$4.68B
– –
-2,000
Closed -$12K
UTHR icon
507
United Therapeutics
UTHR
$25.8B
– –
-31,391
Closed -$2.5M
VAC icon
508
Marriott Vacations Worldwide
VAC
$3.35B
$0 ﹤0.01%
1
– –
VV icon
509
Vanguard Morningstar Large-Cap ETF
VV
$52.4B
– –
-800
Closed -$109K
WAB icon
510
Wabtec
WAB
$49.1B
$0 ﹤0.01%
6
– –
CLR
511
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$0 ﹤0.01%
8
– –
SMRT
512
DELISTED
Stein Mart Inc
SMRT
$0 ﹤0.01%
300
– –
JCP
513
DELISTED
J.C. Penney Company, Inc.
JCP
$0 ﹤0.01%
200
– –
MDR
514
DELISTED
McDermott International
MDR
$0 ﹤0.01%
247
– –
MLNT
515
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
– –
-390
Closed -$1K
ASNA
516
DELISTED
Ascena Retail Group, Inc.
ASNA
$0 ﹤0.01%
9
-1
-10% -$8
BPL
517
DELISTED
Buckeye Partners, L.P.
BPL
– –
-100
Closed -$4K
YMLI
518
DELISTED
VanEck Vectors High Income Infrastructure MLP ETF
YMLI
– –
-5,050
Closed -$55K
AABA
519
DELISTED
Altaba Inc
AABA
– –
-269
Closed -$5K
INSY
520
DELISTED
Insys Therapeutics, Inc.
INSY
$0 ﹤0.01%
740
-25
-3% –
GNCA
521
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-5,000
Closed -$15K
MFGP
522
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$0 ﹤0.01%
+28
New +$388
CLD
523
DELISTED
Cloud Peak Energy Inc
CLD
$0 ﹤0.01%
500
– –
DELL
524
DELISTED
DELL INC
DELL
– –
-119
Closed -$6K
HDY
525
DELISTED
HYPERDYNAMICS CORP (NEW)
HDY
$0 ﹤0.01%
21
– –
18 19 20
21
22

Similar funds

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return
LHR
Lunate Holding RSC Al Maryah Island, Abu Dhabi, United Arab Emirates $211M AUM
HPFG
Hart & Patterson Financial Group Amherst, Massachusetts $206M AUM 7.82% 1-Year Est. Return
GWM
Gray Wealth Management Bangor, Maine $264M AUM 19.5% 1-Year Est. Return
KC
Kades & Cheifetz Berwyn, Pennsylvania $195M AUM 11.87% 1-Year Est. Return
SL
SIB LLC New York, New York $190M AUM 9.27% 1-Year Est. Return
CSWM
Cassady Schiller Wealth Management Cincinnati, Ohio $273M AUM 17.91% 1-Year Est. Return

AlphaMark Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, AlphaMark Advisors held 546 positions worth $239M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

AlphaMark Advisors's Q4 2019 filing shows 36 new, 93 increased, 108 reduced and 33 closed positions. Its largest new stake was Alexion Pharmaceuticals: 29,481 shares worth $3.19M. The largest sale was Celgene Corp, an estimated $4.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Consumer Staples and Technology.

  • AlphaMark Advisors's largest Q4 2019 buy was Alexion Pharmaceuticals: 29,481 shares worth $3.19M.
  • AlphaMark Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.48M increase.
  • AlphaMark Advisors's biggest Q4 2019 reduction was EOG Resources, cutting an estimated $2.91M.
  • AlphaMark Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $4.4M.
  • AlphaMark Advisors's ten largest holdings make up 35% of its $239M portfolio in Q4 2019.
  • AlphaMark Advisors opened 36 new positions and closed 33 in Q4 2019.
  • AlphaMark Advisors's portfolio value rose 3.6% quarter-over-quarter to $239M.

Based on AlphaMark Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.